R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Tariff turbulence: Navigating US trade shifts in the medtech...

The US has been at the centre of a shift in global trade dynamics these last few weeks, resulting from a rise in geopolitical and economic uncertainty.

R&D

Jonah Comstock interviews Dr Dhaval Shah at AAPS

Modelling biologics: Challenges and opportunities, with Dr D...

From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.

R&D

FT US Pharma and Biotech Summit 2025: Live coverage

We’re back this year, this time virtually attending the FT US Pharma and Biotech Summit in New York City, a one-day event where top pharma execs will come together to discuss the major tren

R&D

Multilateral benefit sharing mechanism for digital sequence ...

Since December 2022, and COP decision 15/9, members of the Convention on Biolog

R&D

Q1 Clinical trials round-up: Jan-Mar 2025

The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.

R&D